Clinical and basic research implications of the article 'IGF-1 axis changes with ADT and docetaxel in metastatic prostate cancer'

Endocr Relat Cancer. 2024 Mar 22;31(5):e230362. doi: 10.1530/ERC-23-0362. Print 2024 May 1.
No abstract available

MeSH terms

  • Androgen Antagonists / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols
  • Docetaxel / therapeutic use
  • Humans
  • Insulin-Like Growth Factor I*
  • Male
  • Prostatic Neoplasms* / drug therapy
  • Prostatic Neoplasms* / pathology
  • Treatment Outcome

Substances

  • Docetaxel
  • Insulin-Like Growth Factor I
  • Androgen Antagonists